Psychiatry & Behavioral Health

Editor's Choice

Treatment with SSRIs or venlaxafine associated with increased risk of GI bleeding

In a nested, case-control study published in the Archives of General Psychiatry, investigators observed that the use of selective serotonin-reuptake inhibitors (SSRIs) increased the risk of upper gastrointestinal (GI) tract bleeding; this increased risk was also observed with the serotonin and norepinephrine reuptake inhibitor (SNRI) venlafaxine. This risk may be increased when the agents are used concomitantly with nonsteroidal anti-inflammatory drugs (NSAIDs) and decreased when used concomitantly with acid-suppressing agents.

LATEST ARTICLES

Preventing Adverse Consequences of Sleep Loss and Excessive Sleepiness: Practical Assessment and Management Strategies

Sleep loss may result from poor sleep "hygiene" or may be self-imposed as a result of economic or societal pressures. Small amounts of sleep loss may go unrecognized, but over time loss of sleep is cumulative, and can have negative effects on cognitive functioning, psychological well-being, and physical health.

Then and Now: Television and children

The tenth in a year-long series of commentary reviewing topics published in Contemporary Pediatrics 25 years ago. This month's article discusses the influence of TV on children and the AAP's current stance on the subject.

Optimizing primary care for LGBTQ youth

Caring for lesbian, gay, bisexual, transgender, and questioning youth requires both an understanding of general adolescent cognitive and sexual health development, as well as an awareness of some of the unique medical and social issues these young people may face.

CP Links: LGBTQ links

A collection of links for lesbian, gay, bisexual, transgender, and questioning youth, and their parents, friends, and doctors.

’Crystel’ clear: Study shows etanercept improves depression, anxiety in psoriasis patients

International report — Etanercept therapy helps to improve symptoms of depression and anxiety long-term in patients suffering from moderate-to severe psoriasis, according to the results of the Crystel study.